Universität Wien

322573 VU Drug Delivery to the Lungs - M7/M14 (2024S)

2.00 ECTS (2.00 SWS), SPL 32 - Pharmazie
Continuous assessment of course work

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).

Details

Language: English

Lecturers

Classes

Friday, 07. Juni 2024 - 09:30 - 11:30 Uhr - 2F161- Introduction to the course
Thursday, 13. Juni 2024 - 09:30 - 11:30 Uhr - 2F165 - Lab class "Nebulizer Performance" Gr. 1 and 2
Friday, 14. Juni 2024 - 09:30 - 12:30 Uhr - 2E165 - Lab class "Nebulizer Performance" Gr. 3 and 4
Thursday, 20. Juni 2024 - 09:30 - 11:30 Uhr - 2F161 - Data interpretation and report writing
Friday, 21. Juni 2024 - 09:30 - 11:30 Uhr - 2F161 - Data interpretation and report writing
25.06.2024 - Deadline for submission of the raw data and data analysis
01.07.2024 - Deadline for submission of lab report


Information

Aims, contents and method of the course

In this course you will be introduced to three important topics covering the design of new medications for inhalation: 1) The biopharmaceutics of drug delivery to the lung, 2) considerations for designing a new oral inhaled drug product, and 3) testing aerosol performance of an inhaled product. The activities and schedule are described below. Following this, each section provides additional information on the activities we will perform together, as well as the contributions of each activity to the overall marks.

Assessment and permitted materials

Experiments - 20%
Data analysis - 30%
A written report (5 to 6 pages) of practical results should be prepared following the document "Guide to Scientific Writing" - 50% of the final mark

Minimum requirements and assessment criteria

Examination topics

Reading list


Association in the course directory

MA8, MA23

Last modified: Th 23.05.2024 15:06